nadp has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Białas, AJ; Górski, P; Kurmanowska, Z; Majewski, S; Miłkowska-Dymanowska, J; Szewczyk, K | 1 |
| Binker, MG; Binker-Cosen, AA; Cosen-Binker, LI; Oliver, B; Richards, D | 1 |
2 other study(ies) available for nadp and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Assessment of microvascular function in vivo using flow mediated skin fluorescence (FMSF) in patients with obstructive lung diseases: A preliminary study.
Topics: Adult; Aged; Asthma; Biomarkers; Blood Flow Velocity; Case-Control Studies; Female; Forearm; Humans; Hyperemia; Luminescent Measurements; Male; Microcirculation; Middle Aged; NADP; Predictive Value of Tests; Preliminary Data; Pulmonary Disease, Chronic Obstructive; Regional Blood Flow; Skin | 2020 |
LPS-stimulated MUC5AC production involves Rac1-dependent MMP-9 secretion and activation in NCI-H292 cells.
Topics: Cell Line, Tumor; ErbB Receptors; Humans; Lipopolysaccharides; Matrix Metalloproteinase 9; Mucin 5AC; Mucus; NADP; Phosphatidylinositol 3-Kinases; Pulmonary Disease, Chronic Obstructive; rac1 GTP-Binding Protein; Reactive Oxygen Species; Respiratory Mucosa; Signal Transduction | 2009 |